Jefferies Upgrades AveXis To Buy Following Positive AVXS-101 Data, Doc Feedback
August 12, 2016 at 09:03 AM EDT
The updated AVXS-101 data released by AveXis Inc (NASDAQ: AVXS) suggests that the FDA may allow for a single-arm pivotal trial in SMA ...